Pharma · Private company
Grifols Biologicals, LLC
Track this companyFree. Adds Grifols Biologicals, LLC to your Dealase workspace and tells you when its record changes.
Clinical trials101 recruiting or active
Pipeline programs1From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline1
- Gamunex-C, 10% Injectable SolutionPhase 3 · Chronic Lymphocytic Leukemia, Multiple Myeloma, or Non-Hodgkin LymphomaClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials10
- A Clinical Trial to Evaluate Efficacy, Safety, and Pharmacokinetics of Gamunex in Participants With Secondary Antibody Deficiency Associated With Chronic Lymphocytic Leukemia, Multiple Myeloma, or Non-Hodgkin LymphomaPHASE3 · RECRUITING · started May 11, 2026ClinicalTrials.gov NCT07582432 · fetched Nov 12, 2026
- Survey of Human Rabies Immune Globulin Safety in ChildrenTERMINATED · started Feb 22, 2023ClinicalTrials.gov NCT05382650 · fetched Nov 12, 2026
- Monotherapy IVIG Gamunex-C for HMG-CoA Reductase Auto-Antibody Positive Necrotizing Myopathy Treatment (The MIGHT Trial)PHASE2 · WITHDRAWN · started May 1, 2022ClinicalTrials.gov NCT04450654 · fetched Nov 12, 2026
- Antithrombin III in Infectious Disease Caused by COVID-19PHASE2 · TERMINATED · started Jul 6, 2021ClinicalTrials.gov NCT04899232 · fetched Nov 12, 2026
- Preventing Inhibitor Recurrence IndefinitelyPHASE4 · UNKNOWN · started Sep 21, 2020ClinicalTrials.gov NCT04621916 · fetched Nov 12, 2026
- IVIG (Gamunex-C) Treatment Study for POTS SubjectsPHASE1_PHASE2 · COMPLETED · started Oct 29, 2018ClinicalTrials.gov NCT03919773 · fetched Nov 12, 2026
- Alphanate in Immune Tolerance Induction TherapyPHASE2 · TERMINATED · started Jan 3, 2018ClinicalTrials.gov NCT03095287 · fetched Nov 12, 2026
- The Efficacy Of Intravenous Immunoglobulin Therapy In Treatment Induced Neuropathy Of DiabetesPHASE2 · TERMINATED · started Sep 11, 2017ClinicalTrials.gov NCT02915263 · fetched Nov 12, 2026
- Efficacy and Safety of Plasma Exchange With Albutein® 5% in Participants With Amyotrophic Lateral SclerosisPHASE2 · COMPLETED · started Aug 29, 2016ClinicalTrials.gov NCT02872142 · fetched Nov 12, 2026
- A Study to Evaluate Albumin and Immunoglobulin in Alzheimer's DiseasePHASE2_PHASE3 · COMPLETED · started Apr 19, 2012ClinicalTrials.gov NCT01561053 · fetched Nov 12, 2026